Skip to main content
. 2012 Jul 23;2:32. doi: 10.1186/2110-5820-2-32

Table 2.

Principal characteristics of the randomized controlled trials assessing the role of PCT-guided antibiotic stewardship in adult critically ill patients

  Trial Sample size Rate of exclusion (%) Infections Community/nosocomial Pneumonia PCT assay Minimum duration AB therapy Decision to start antibiotics (no AB), PCT/control Duration of antibiotic therapy, PCT/control, days Overruling PCT algorithm (%) LOS ICU, PCT/control, days Superinfection, PCT/control, N(%) Relapse, PCT/control, N(%) Mortality 28d, PCT/control, N(%) Mortality 60d, PCT/control, N(%)
Svoboda, 2007 [43]
 
72
381 (84)
0/72
NA
PCT-Q
 
 
 
 
16.1 ± 6.9/19.4 ± 8.9
 
 
10/38 (26 %)/13/34 (38 %)
 
Nobre, 2008 [41]
ProSEP
79
203 (72)
53/26
52
TRACE
 
 
8 (4–27)/14 (6–39)
19
4 (1–21)/7 (1–91)
7/31 (22.5 %)/11/37 (29.7 %)
1/39 (2.6 %)/1/40 (2.5 %)
8/39 (20.5 %)/8/40 (20 %)
 
Schroeder, 2009 [44]
 
27
98 (78)
0/27
8
PCT LIA
yes
 
6.6 ± 1.1/8.3 ± 0.7
 
16.4 ± 8.3/16.7 ± 5.6
 
 
3/14 (21.4 %)/3/13 (23.1 %)
 
Stolz, 2009 [45]
ProVAP
101
63 (38)
0/101
101
TRACE
yes
 
10 (6–16)/15 (10–23)
16
13 (7–21)/13.5 (8–22.2)
7/51 (13.7 %)/6/50 (12 %)
 
8/51 (16 %)/12/50 (24 %)
 
Hochreiter, 2009 [46]
ProSICU
110
285 (72)
0/110
43
PCT LIA
 
 
5.9 ± 1.7/7.9 ± 0.5
 
15.5 ± 12.5/17.7 ± 10.1
 
 
15/57 (26.3 %)/14/53 (26.4 %)
 
Bouadma, 2010 [42]
PRORATA
601
685 (52)
326/275
394
TRACE
yes
4 (1.7 %)/15 (4.8 %)
10.3 ± 7.7/13.3 ± 7.6
53
15.9 ± 16.1/14.4 ± 14.1
106/307 (34.5 %)/97/314 (30.9 %)
20/307 (6.5 %)/16/314 (5.1 %)
65/307 (21.2 %)/64/314 (20.4 %)
92/307 (30 %)/82/314 (26.1 %)
Jensen, 2011 [47] PASS 1200 3 (0.3) 480/720 666 TRACE     6 (3–11)/4 (3–10) 17.9 6 (3–12)/5 (3–11)     190/604 (31.5 %)/191/596 (32 %) 231/604 (38.2 %)/220/596 (36.9 %)

Results are expressed as mean ± standard deviation or median (interquartile range) unless otherwise indicated.

AB = antibiotics; LOS = length of stay; PCT = procalcitonin; PCT LIA = luminescence immunoassay; PCT-Q = semiquantitative immunochromatographic method; TRACE = time-resolved amplified cryptate emission.